Citigroup Inc Spring Works Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 55,525 shares of SWTX stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,525

Previous 35,495 56.43%

Holding current value

$1.92 Million

Previous $1.34 Million 33.06%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$32.04 - $42.76 $641,761 - $856,482	20,030 Added 56.43%	55,525 $1.78 Million
Q2 2024 Aug 12, 2024	SELL	$36.06 - $47.62 $4.62 Million - $6.1 Million	-128,050 Reduced 78.3%	35,495 $1.34 Million
Q1 2024 May 10, 2024	BUY	$36.5 - $52.5 $3.06 Million - $4.4 Million	83,769 Added 105.01%	163,545 $8.05 Million
Q4 2023 Feb 09, 2024	BUY	$18.94 - $37.24 $5,947 - $11,693	314 Added 0.4%	79,776 $2.91 Million
Q3 2023 Nov 09, 2023	SELL	$23.12 - $31.38 $195,548 - $265,412	-8,458 Reduced 9.62%	79,462 $1.84 Million
Q2 2023 Aug 10, 2023	SELL	$23.15 - $32.71 $2.14 Million - $3.03 Million	-92,522 Reduced 51.28%	87,920 $2.31 Million
Q1 2023 May 11, 2023	BUY	$24.97 - $34.05 $984,517 - $1.34 Million	39,428 Added 27.96%	180,442 $4.64 Million
Q4 2022 Feb 09, 2023	SELL	$21.73 - $28.72 $1.81 Million - $2.4 Million	-83,416 Reduced 37.17%	141,014 $3.67 Million
Q3 2022 Nov 10, 2022	SELL	$24.1 - $39.66 $714,131 - $1.18 Million	-29,632 Reduced 11.66%	224,430 $6.4 Million
Q2 2022 Aug 10, 2022	BUY	$18.36 - $60.07 $4.31 Million - $14.1 Million	234,558 Added 1202.61%	254,062 $6.26 Million
Q1 2022 May 12, 2022	SELL	$48.97 - $65.46 $2.36 Million - $3.16 Million	-48,214 Reduced 71.2%	19,504 $1.1 Million
Q4 2021 Feb 10, 2022	BUY	$53.3 - $75.84 $1.58 Million - $2.25 Million	29,692 Added 78.08%	67,718 $4.2 Million
Q3 2021 Nov 10, 2021	BUY	$62.66 - $88.26 $2.38 Million - $3.36 Million	38,026 New	38,026 $2.41 Million

Others Institutions Holding SWTX

# of Institutions

239

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.16B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account